These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11849453)

  • 1. Studies on the pathophysiology of the low urine pH in patients with uric acid stones.
    Kamel KS; Cheema-Dhadli S; Halperin ML
    Kidney Int; 2002 Mar; 61(3):988-94. PubMed ID: 11849453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies to identify the basis for an alkaline urine pH in patients with calcium hydrogen phosphate kidney stones.
    Kamel KS; Shafiee MA; Cheema-Dhadli S; Halperin ML
    Nephrol Dial Transplant; 2007 Feb; 22(2):424-31. PubMed ID: 17107965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent uric acid stones.
    Kamel KS; Cheema-Dhadli S; Shafiee MA; Davids MR; Halperin ML
    QJM; 2005 Jan; 98(1):57-68. PubMed ID: 15625355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
    Abate N; Chandalia M; Cabo-Chan AV; Moe OW; Sakhaee K
    Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
    Trinchieri A; Esposito N; Castelnuovo C
    Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and prevention of uric acid stones].
    Ferrari P; Bonny O
    Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
    Sakhaee K; Adams-Huet B; Moe OW; Pak CY
    Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO; Wipplinger J
    Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis.
    Bobulescu IA; Park SK; Xu LHR; Blanco F; Poindexter J; Adams-Huet B; Davidson TL; Sakhaee K; Maalouf NM; Moe OW
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):411-420. PubMed ID: 30745301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary pH and stone formation.
    Wagner CA; Mohebbi N
    J Nephrol; 2010; 23 Suppl 16():S165-9. PubMed ID: 21170875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid stone disease: lessons from recent human physiologic studies.
    Tran TVM; Maalouf NM
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):407-413. PubMed ID: 32398609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical profile of idiopathic uric acid nephrolithiasis.
    Pak CY; Sakhaee K; Peterson RD; Poindexter JR; Frawley WH
    Kidney Int; 2001 Aug; 60(2):757-61. PubMed ID: 11473659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.